Should You Buy BioCardia Inc (BCDA) Stock Wednesday Morning?

BioCardia Inc (BCDA) is lower by Wednesday morning, with the stock declining -4.67% in pre-market trading to 1.02. BCDA's short-term technical score of 100 indicates that the stock has traded more bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 123 out of 146 industries, the stock ranks higher than 99% of stocks. BioCardia Inc has risen 143.18% over the past month, closing at $0.40 on October 18. During this period of time, the stock fell as low as $0.37 and as high as $0.44. BCDA has an average analyst recommendation of Buy. The company has an average price target of $5.00.

BCDA has an Overall Score of 93. Find out what this means to you and get the rest of the rankings on BCDA!

See Full BCDA Report

BioCardia Inc has a Long-Term Technical rank of 84. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 16% of the market scoring higher. In the Biotechnology industry which is number 130 by this metric, BCDA ranks better than 130% of stocks.

Important Dates for Investors in BCDA:

-BioCardia Inc is set to release earnings on 2024-02-06. Over the last 12 months, the company has reported EPS of $-0.63. -We do not have a set dividend date for BioCardia Inc at this time. Click Here To Get The Full Report on BioCardia Inc (BCDA)